Joseph S Zakrzewski Insider Trading $XLRN ACCELERON PHARMA INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Joseph S Zakrzewski.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Joseph S Zakrzewski. Joseph S Zakrzewski is in AMARIN CORP PLC\UK ($AMRN) and Director in AMARIN CORP PLC\UK ($AMRN) and Director in SANGAMO THERAPEUTICS, INC ($SGMO) and Director in INSULET CORP ($PODD) and Director in ACCELERON PHARMA INC ($XLRN) and Director in Cyteir Therapeutics, Inc. ($CYT).
Joseph S Zakrzewski in ACCELERON PHARMA INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Joseph S Zakrzewski: Director
Holdings: 44,499 shares
Current Value: $1,056,406
Latest Transaction: Apr 05 2021
$XLRN Market Capitalization: $879.48M
$XLRN Previous Close: $23.74
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Joseph S Zakrzewski in ACCELERON PHARMA INC
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, XLRN, AMRN, CYT, PODD, SGMO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | M | 24.11 | 10,000 | 241,100 | 0 | |
| Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Sell | S | 142.27 | 1,100 | 156,497 | 34,499 | 35.6 K to 34.5 K (-3.09 %) |
| Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Sell | S | 141.28 | 2,152 | 304,035 | 35,599 | 37.8 K to 35.6 K (-5.70 %) |
| Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Sell | S | 140.31 | 6,748 | 946,812 | 37,751 | 44.5 K to 37.8 K (-15.16 %) |
| Apr 05 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Buy | M | 24.11 | 10,000 | 241,100 | 44,499 | 34.5 K to 44.5 K (+28.99 %) |
| Apr 02 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | M | 24.11 | 10,000 | 241,100 | 10,000 | |
| Apr 02 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Sell | S | 135.67 | 1,600 | 217,072 | 34,499 | 36.1 K to 34.5 K (-4.43 %) |
| Apr 02 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Sell | S | 135.22 | 1,700 | 229,874 | 36,099 | 37.8 K to 36.1 K (-4.50 %) |
| Apr 02 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Sell | S | 134.27 | 6,596 | 885,645 | 37,799 | 44.4 K to 37.8 K (-14.86 %) |
| Apr 02 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Sell | S | 132.61 | 104 | 13,791 | 44,395 | 44.5 K to 44.4 K (-0.23 %) |
| Apr 02 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Buy | M | 24.11 | 10,000 | 241,100 | 44,499 | 34.5 K to 44.5 K (+28.99 %) |
| Feb 02 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | A | 115.53 | 3,222 | 372,238 | 3,222 | |
| Feb 02 2021 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 1,622 | 0 | 34,499 | 32.9 K to 34.5 K (+4.93 %) |
| Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | A | 52.99 | 8,185 | 433,723 | 8,185 | |
| Jan 24 2020 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 1,377 | 0 | 32,877 | 31.5 K to 32.9 K (+4.37 %) |
| Jan 09 2020 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | M | 3.88 | 18,750 | 72,750 | 0 | |
| Jan 09 2020 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Buy | M | 3.88 | 18,750 | 72,750 | 31,500 | 12.8 K to 31.5 K (+147.06 %) |
| Jun 17 2019 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Buy | P | 38.05 | 5,000 | 190,250 | 12,750 | 7.8 K to 12.8 K (+64.52 %) |
| Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | A | 41.64 | 7,500 | 312,300 | 7,500 | |
| Jan 29 2019 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 1,250 | 0 | 7,750 | 6.5 K to 7.8 K (+19.23 %) |
| Mar 05 2018 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | A | 40.61 | 7,500 | 304,575 | 7,500 | |
| Mar 05 2018 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 1,250 | 0 | 6,500 | 5.3 K to 6.5 K (+23.81 %) |
| Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | A | 30.17 | 7,500 | 226,275 | 7,500 | |
| Mar 14 2017 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Grant | A | 0.00 | 1,250 | 0 | 5,250 | 4 K to 5.3 K (+31.25 %) |
| Jan 03 2017 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Buy | P | 25.50 | 4,000 | 102,000 | 4,000 | 0 to 4 K |
| Mar 07 2016 | XLRN | ACCELERON PHARMA I ... | Zakrzewski Joseph S | Director | Option Exercise | A | 27.97 | 10,000 | 279,700 | 10,000 |
Page: 1